Lululemon’s stock bounces after analyst recommends investors ‘build positions’

Lululemon Athletica Inc.’s stock climbed 1.1% in premarket trade Friday, bouncing from a sharp selloff in the previous session, after the yoga-gear seller was upgraded at Robert W. Baird & Co., which cited “compelling” valuation at current levels. Analyst Mark Altschwager raised his rating to outperform, after being at neutral for the past 15 months. Meanwhile, he cut his stock price target to $69, which is 29% above Thursday’s closing price of $53.54, from $73. On Thursday, the company beat fiscal second-quarter profit and sales expectations, and raised its full-year earnings outlook, but the stock plunged 16% to a nine-month low on concerns over a surge in inventory levels and disappointing gross margin. Altschwager said he believes inventory issues will correct during the second half of the year and gross margins could bottom in the fourth quarter. Coupled with encouraging sales momentum and product innovation, he said the pullback in the stock produced a “compelling” risk-versus-reward profile at current levels. “We believe investors should use near-term volatility to build positions,” Altschwager wrote in a note to clients. The stock has lose 4% year to date through Thursday, while the S&P 500 has dropped 5.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

China mulls trillion-yuan fiscal stimulus: report

Beijing is considering injecting more than 1 trillion yuan ($16 billion) into the Chinese economy over the next three years, state news agency Xinhua said on Friday, citing a report from the China International Capital Corporation. According to the CICC report, the stimulus package will be between 1.2 trillion and 1.5 trillion yuan and is likely to drive a total potential investment of 5 trillion to 7 trillion yuan in the next three years. That’s as much as 3.4% of the 2015 gross domestic product each year. The investment projects will be funded by commercial lenders, private investors and policy banks, the report said. Earlier this week, China’s finance ministry said the country will roll out a “more forceful” fiscal policy to stimulate growth.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Winnebago interim CEO Olson to step down

Winnebago Industries Inc. said Thursday its interim Chief Executive Robert J. Olson will be stepping down Sept. 24. If the CEO position has not been filled by then, Chairman of the Board Larry Erickson will temporarily serve as chief executive. Shares of the motor-home manufacturer were flat in late trading Thursday after ending the regular session up 0.9%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Actelion and ZS Pharma confirm acquisition talks

Biopharmaceuticals giant Actelion Ltd. confirmed Thursday afternoon that it has held talks with potential acquisition target ZS Pharma Inc. Actelion, based in Switzerland, issued a brief statement that said it “has initiated preliminary discussions” with ZS Pharma, and that it would not give further comment. ZS Pharma issued a similar statement minutes later. “ZS Pharma regularly and routinely explores opportunities with various strategic partners and will continue to do so,” the statement read. “These discussions may or may not lead to any transaction.” Bloomberg News reported earlier Thursday that the two companies had discussed a deal that would value Texas-based ZS Pharma at $2.5 billion. ZS Pharma stock roared higher after the Bloomberg report, closing with a 28.4% gain at $74.73 that pushed the company’s market cap closer to $2 billion.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Private equity Siris to buy Premiere Global for $1 billion

Private-equity company Siris Capital Group has agreed to buy Premiere Global Services Inc. , or PGi, for about $1 billion, PGi said Thursday. Under the terms of the agreement, Siris will acquire all outstanding shares of the software company for $14 a share, a premium of 23% over PGi’s Thursday closing of $11.35. Shares of PGi soared 21% in after-hours trading after ending the regular session up 2.1%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Actelion confirms talks with ZS Pharma

Biopharmaceuticals giant Actelion Ltd. confirmed Thursday afternoon that it has held talks with potential acquisition target ZS Pharma Inc. Actelion, based in Switzerland, issued a brief statement that said it “has initiated preliminary discussions” with ZS Pharma, and that it would not give further comment. Bloomberg News reported earlier Thursday that the two companies had discussed a deal that would value Texas-based ZS Pharma at $2.5 billion. ZS Pharma stock roared higher after the Bloomberg report, closing with a 28.4% gain at $74.73 that pushed the company’s market cap closer to $2 billion.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News